The use of medicinal mushrooms can become an attractive proposition for people looking to support their immune system during their treatment for cancer. Guaranteeing the content of immune-active constituents is important for these consumers, yet quality concerns have been raised for products available on the internet. We will report on the quality of commercially available extracts of C. versicolor, seeking to build consensus on production and quality assurance methods needed.